These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 38069884)

  • 1. [Actual strategies for preventing type-1 diabetes: international literature review].
    Grechushkina NA
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2023 Oct; 31(Special Issue 2):1189-1196. PubMed ID: 38069884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.
    Woldaregay AZ; Årsand E; Walderhaug S; Albers D; Mamykina L; Botsis T; Hartvigsen G
    Artif Intell Med; 2019 Jul; 98():109-134. PubMed ID: 31383477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technological Developments and Quality of Life in Type 1 Diabetes Mellitus Patients: A Review of the Modern Insulin Analogues, Continuous Glucose Monitoring and Insulin Pump Therapy.
    Benioudakis E; Karlafti E; Kalaitzaki A; Kaiafa G; Savopoulos C; Didangelos T
    Curr Diabetes Rev; 2022; 18(7):e031121197657. PubMed ID: 34732118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of type 1 diabetes.
    Rabinovitch A; Skyler JS
    Med Clin North Am; 1998 Jul; 82(4):739-55. PubMed ID: 9706119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of immunological injury in type 1 diabetes].
    Vega-Anaya GC; Hernández-Lomelí A; Hernández-Montiel HL
    Rev Med Inst Mex Seguro Soc; 2009; 47(5):515-22. PubMed ID: 20550861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease.
    Ziegler AG; Bonifacio E; Powers AC; Todd JA; Harrison LC; Atkinson MA
    Diabetes; 2016 Nov; 65(11):3233-3239. PubMed ID: 27959859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemia prevention via pump attenuation and red-yellow-green "traffic" lights using continuous glucose monitoring and insulin pump data.
    Hughes CS; Patek SD; Breton MD; Kovatchev BP
    J Diabetes Sci Technol; 2010 Sep; 4(5):1146-55. PubMed ID: 20920434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated T lymphocytes from patients with high risk of type I diabetes mellitus have different ability to produce interferon-gamma, interleukin-6 and interleukin-10 and undergo anti-CD95 induced apoptosis after insulin stimulation.
    Tchórzewski H; Głowacka E; Banasik M; Lewkowicz P; Szałapska-Zawodniak M
    Immunol Lett; 2001 Jan; 75(3):225-34. PubMed ID: 11166380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.
    Joubert M; Reznik Y
    Diabetes Res Clin Pract; 2012 Jun; 96(3):294-305. PubMed ID: 22209014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(2):1-160. PubMed ID: 29541282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
    Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
    Durinovic-Belló I
    Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 diabetes and pregnancy: An update on glucose monitoring and insulin treatment.
    Amigó J; Corcoy R
    Endocrinol Diabetes Nutr (Engl Ed); 2022; 69(6):433-441. PubMed ID: 35787359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin during pregnancy, labour and delivery.
    de Valk HW; Visser GH
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived Usefulness of Continuous Glucose Monitoring Devices at the Workplace: Secondary Analysis of Data From a Qualitative Study.
    Scharf J; Nguyen XQ; Vu-Eickmann P; Krichbaum M; Loerbroks A
    J Diabetes Sci Technol; 2019 Mar; 13(2):242-247. PubMed ID: 30027749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.
    Breton MD; Patek SD; Lv D; Schertz E; Robic J; Pinnata J; Kollar L; Barnett C; Wakeman C; Oliveri M; Fabris C; Chernavvsky D; Kovatchev BP; Anderson SM
    Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.